Besides, it could not be ignored that the uniqueness of samples might exaggerate the correlation between the studied 6 genetic polymorphisms and CHD risk, or neglect the role of some other vital polymorphisms within VEGFA and VEGFR2 in susceptibility to CHD. This evidence concerns the gene VEGFA and coronary artery disorder.